Delayed Response to Glucocorticoids in Daptomycin Lung.

Abdelrahman Nanah, Anika Sasidharan Nair, James Stoller
Author Information
  1. Abdelrahman Nanah: Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH. ORCID
  2. Anika Sasidharan Nair: Respiratory Institute, Cleveland Clinic Foundation, Cleveland, OH.
  3. James Stoller: Respiratory Institute, Cleveland Clinic Foundation, Cleveland, OH.

Abstract

No abstract text available.

References

  1. Humphries RM, Pollett S, Sakoulas G. A current perspective on daptomycin for the clinical microbiologist. Clin Microbiol Rev. 2013;26:759–780.
  2. Wu C, Li Z, Wang C, et al. Clinical characteristics, management, and outcome of eosinophilic pneumonia associated with daptomycin. Med Clin (Barc). 2023;160:17–22.
  3. Uppal P, LaPlante KL, Gaitanis MM, et al. Daptomycin-induced eosinophilic pneumonia - a systematic review. Antimicrob Resist Infect Control. 2016;5:55.
  4. Di Lorenzo A, Rindi LV, Campogiani L, et al. Daptomycin-induced eosinophilic pneumonia: a case report and systematic review. Chemotherapy. 2023.
  5. Abd Algayoum R, Elsherif A, Khan ZH, et al. Daptomycin-induced eosinophilic pneumonia mimicking multifocal pneumonia. Cureus. 2022;14:e30521.
  6. Fujii E, Arita T, Uejima T, et al. Blood culture-negative prosthetic valve endocarditis and daptomycin-associated eosinophilic pneumonia: a case report. J Cardiol Cases. 2022;25:354–358.
  7. Watts A, Toquica Gahona CC, Raj K. Multifocal pneumonia amidst the global COVID-19 pandemic: a case of daptomycin-induced eosinophilic pneumonia. Cureus. 2021;13:e16002.
  8. Portalatin GM, Chin JA, Foster B, et al. Daptomycin-induced acute eosinophilic pneumonia. Cureus. 2021;13:e13509.
  9. Storandt MH, Matta A. Acute eosinophilic pneumonia: a rare complication of daptomycin therapy. Cureus. 2020;12:e6803.
  10. Kumar S, Acosta-Sanchez I, Rajagopalan N. Daptomycin-induced acute eosinophilic pneumonia. Cureus. 2018;10:e2899.
  11. Abelenda Alonso G, Montes Rodríguez I, Martín Torres J, et al. Daptomycin eosinophilic pneumonia: an adverse effect to be aware of. Rev Esp Quimioter. 2018;31:282–284.
  12. Raru Y, Zeid F, Browning S, et al. Two patients with daptomycin induced eosinophilic pneumonia with different presentations and treatment. Respir Med Case Rep. 2018;23:29–32.
  13. Hirai J, Hagihara M, Haranaga S, et al. Eosinophilic pneumonia caused by daptomycin: six cases from two institutions and a review of the literature. J Infect Chemother. 2017;23:245–249.
  14. Rachid M, Ahmad K, Saunders-Kurban M, et al. Daptomycin-induced acute eosinophilic pneumonia: late onset and quick recovery. Case Rep Pulmonol. 2017;2017:8525789.
  15. Hatipoglu M, Memis A, Turhan V, et al. Possible daptomycin-induced acute eosinophilic pneumonia in a patient with diabetic foot infection. Int J Antimicrob Agents. 2016;47:414–415.
  16. Akcaer M, Karakas A, Tok D, et al. Eosinophilic pneumonia: daptomycin-induced lung complication. Médecine et Maladies Infectieuses. 2016;46:166–168.
  17. Roux S, Ferry T, Chidiac C, et al. Daptomycin-induced eosinophilic pneumonia. Int J Infect Dis. 2015;37:95–96.
  18. Wojtaszczyk A, Jankowich M. Dyspnea on daptomycin: eosinophilic pneumonia. R I Med J. 2015;98:41–43.
  19. Chiu SY, Faust AC, Dand HM. Daptomycin-induced eosinophilic pneumonia treated with intravenous corticosteroids. J Pharm Pract. 2015;28:275–279.
  20. Yusuf E, Perrottet N, Orasch C, et al. Daptomycin-associated eosinophilic pneumonia in two patients with prosthetic joint infection. Surg Infect (Larchmt). 2014;15:834–837.
  21. Patel JJ, Antony A, Herrera M, et al. Daptomycin-induced acute eosinophilic pneumonia. WMJ. 2014;113:199–201.
  22. Rether C, Conen A, Grossenbacher M, et al. A rare cause of pulmonary infiltrates one should be aware of: a case of daptomycin-induced acute eosinophilic pneumonia. Infection. 2011;39:583–585.
  23. Kalogeropoulos AS, Tsiodras S, Loverdos D, et al. Eosinophilic pneumonia associated with daptomycin: a case report and a review of the literature. J Med Case Rep. 2011;5:13.
  24. Miller BA, Gray A, Leblanc TW, et al. Acute eosinophilic pneumonia secondary to daptomycin: a report of three cases. Clin Infect Dis. 2010;50:e63–e68.
  25. Lal Y, Assimacopoulos AP. Two cases of daptomycin-induced eosinophilic pneumonia and chronic pneumonitis. Clin Infect Dis. 2010;50:737–740.
  26. Cobb E, Kimbrough RC, Nugent KM, et al. Organizing pneumonia and pulmonary eosinophilic infiltration associated with daptomycin. Ann Pharmacother. 2007;41:696–701.
  27. Hayes D Jr, Anstead MI, Kuhn RJ. Eosinophilic pneumonia induced by daptomycin. J Infect. 2007;54:e211–e213.

MeSH Term

Humans
Anti-Bacterial Agents
Daptomycin
Glucocorticoids
Lung
Staphylococcal Infections
Time Factors
Tomography, X-Ray Computed
Treatment Outcome

Chemicals

Anti-Bacterial Agents
Daptomycin
Glucocorticoids

Word Cloud

Created with Highcharts 10.0.0DelayedResponseGlucocorticoidsDaptomycinLung

Similar Articles

Cited By